Table 1.
Study | Na | Treatment groups | Age | Visual acuity testing |
Baseline amblyopia severity |
Outcome stereoacuity exam |
---|---|---|---|---|---|---|
15 | 130b | Patching ± atropine Optical correction alone |
7 to <18 | E-ETDRS | 20/40–20/100 | |
26 | 64b | Daily atropine Weekend atropine |
3 to <7 | ATS-HOTV | 20/40–20/80 | |
37 | 74 | 2-hour patching Glasses alone |
3 to <7 | ATS-HOTV | 20/40–20/100 | |
48 | 158 (141) | 2-hour patching + near activities 2-hour patching + distance activities |
3 to <7 | ATS-HOTV | 20/40–20/100 | 17 ± 1 week |
59 | 60 | Weekend atropine Weekend atropine + plano lens |
3 to <7 | ATS-HOTV | 20/40–20/100 | |
610 | 74 (40) | 2-hour patching Weekend atropine |
7 to <13 | E-ETDRS | 20/40–20/100 | 17 ± 1 week |
711 | 73 (67) | 2-hour patching Bangerter (full-time) |
3 to <10 | ATS-HOTV E-ETDRS |
20/40–20/80 | 24 ± 2 weeks |
ATS-HOTV, Amblyopia Treatment Study HOTV; E-ETDRS, Electronic Early Treatment for Diabetic Retinopathy Study.
Sample sizes are based on the cohort included in the baseline stereoacuity analysis; sample sizes enclosed within the parentheses indicate the number of subjects included in the outcome stereoacuity analysis from specific protocols.
Stability of visual acuity in glasses not required for study eligibility at enrollment.